Mirabella Financial Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,510
Closed -$220K 504
2022
Q1
$220K Buy
+3,510
New +$220K 0.02% 385